Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Merus N.V.

MRUSNASDAQ
Healthcare
Biotechnology
$90.00
$0.00(0.00%)
U.S. Market opens in 16h 15m

Merus N.V. (MRUS) Stock Overview

Explore Merus N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6.8B
P/E Ratio-19.52
EPS (TTM)$-5.28
ROE-0.51%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 Months$109.31
1 Year Target$159.88

MRUS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Merus N.V. (MRUS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 9.59, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $159.88.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -19.52 and a market capitalization of 6.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-5.12%
6-Month Change
37.28%
Year-to-Date (YTD) Change
N/A
1-Year Change
127.22%
3-Year Change
485.94%
5-Year Change
239.62%
All-Time (Max) Change
796.41%

Contact Information

31 30 253 8800
Yalelaan 62, Utrecht, NaN, 3584 CM

Company Facts

2,600 Employees
IPO DateMay 19, 2016
CountryNL

Frequently Asked Questions